Accessibility Menu
Imricor Medical Systems logo

Imricor Medical Systems(ASX) IMR

Market CapA$683.08MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)+36%
5 Year+71%
1 Year+29%
1 Month-1%
A$1.84
-3.68%
-0.07Today
Imricor Medical Systems last closing stock price
MetricPriceDate
Last closeAUD 1.842026-09-02
Imricor Medical Systems stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.41%AUD 1.942026-08-26
1 month-1.34%AUD 1.862026-08-03
3 month+5.46%AUD 1.742026-06-04
Year to date+19.93%AUD 1.532025-12-31
1 year+28.77%AUD 1.432025-09-02
3 year+186.72%AUD 0.642023-09-01
5 year+70.7%AUD 1.082021-09-03
Since inception+35.66%AUD 1.402019-08-30

Imricor Medical Systems Financials at a Glance

Market Cap

A$683.08MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$771.94K

Net Income (TTM)

-$66.94M

EPS (TTM)

-A$0.13

P/E Ratio

-14.92

Dividend

A$0.00

Beta (Volatility)

0.04 (Low)

Price

A$1.84

Volume

0

Open

A$1.95

Previous Close

A$1.84

Daily Range

A$1.84 - A$2.00

52-Week Range

A$1.28 - A$2.25

Estimated Earnings Date

Dec 2, 2026

IMR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Imricor Medical Systems

Imricor Medical Systems, Inc. is a medical device company specializing in MRI-compatible products for cardiac catheter ablation procedures. The company designs, manufactures, and distributes innovative solutions aimed at improving patient outcomes in the United States, Europe, and the Middle East.

Products and Services
  • Vision-MR Ablation Catheter 2.0 for cardiac ablation
  • NorthStar mapping system for real-time MRI imaging
  • Advantage-MR EP Recorder / Stimulator for enhanced procedure efficiency
Growth Outlook
  • Expanding market for MRI-compatible medical devices is projected to grow significantly
  • Increased adoption of cardiac ablation procedures drives demand for innovative solutions
  • Strategic partnerships and collaborations enhance market reach and product offerings
Financial Highlights
  • Recent quarterly revenue of 24,643, indicating potential for growth
  • Cash and short-term investments totaled 67.5 million, providing operational flexibility
  • Trailing twelve months (TTM) cash flow from operations shows a focus on long-term sustainability
Imricor Medical Systems, Inc. operates in the healthcare sector, specifically within medical specialties, and is headquartered in Burnsville, Minnesota. The company has developed a range of products that leverage MRI technology to enhance cardiac procedures, which is a growing area in the medical field. The recent quarterly revenue indicates a positive trend, suggesting that the company is on a path to capitalize on the expanding market for MRI-compatible devices. With a strong cash position, Imricor is well-positioned to invest in research and development, further enhancing its product offerings and market presence. The focus on strategic partnerships may also provide additional avenues for growth, making Imricor an intriguing option for potential investors interested in the healthcare technology sector.
AI Generated • Aug 21, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Steven Wedan

Website

www.imricor.com

Headquarters

Burnsville, MN 55337, US

IMR Financials

Key Financial Metrics (TTM)

Gross Margin

-2310.42%

Operating Margin

-22678.23%

Net Income Margin

-30813.40%

Return on Equity

-184.93%

Return on Capital

-62.90%

Return on Assets

-51.01%

Earnings Yield

-6.70%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$683.08MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

358.57M

Volume

0

Avg. Volume

387.70K

Financials (TTM)

Gross Profit

-$3.51M

Operating Income

-$41.42M

EBITDA

-$39.99M

Operating Cash Flow

-$35.99M

Capital Expenditure

-$952.15K

Free Cash Flow

-$36.94M

Cash & ST Invst.

$67.46M

Total Debt

$34.02M

Imricor Medical Systems Performance Analysis

Imricor Medical Systems annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,177,11326.9%
20232023-12-31USD 927,387-21.2%
20242024-12-31USD 1,454,55756.8%
20252025-12-31USD 453,323-68.8%
Imricor Medical Systems sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3135.3%
Q22025-06-30-82.2%
Q42025-12-31-1.3%
Q22026-06-30-74.6%
Imricor Medical Systems annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.17-14.5%
20232023-12-31USD -0.2226.7%
20242024-12-31USD -0.20-7.7%
20252025-12-31USD -0.13-36.7%
Imricor Medical Systems sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-146.4%
Q22025-06-3075.0%
Q42025-12-31-73.9%
Q22026-06-30-107.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$24.64K

-94.0%

Gross Profit

-$1.37M

-153.7%

Gross Margin

-55.59%

N/A

Market Cap

A$683.08MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$8.76M

N/A

Employees

78

N/A

Net Income

-$25.14M

-266.6%

EBITDA

-$15.41M

-100.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$67.46M

+4387.7%

Total Debt

$34.02M

+261.2%

Accounts Receivable

$254.61K

-18.4%

Inventory

$1.35M

-27.6%

Long Term Debt

$524.03K

-94.1%

Short Term Debt

$33.50M

+5471.5%

Return on Assets

-51.01%

N/A

Return on Invested Capital

-83.73%

N/A

Free Cash Flow

-$14.63M

-81.7%

Operating Cash Flow

-$14.03M

-75.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AYA.AXArtrya Limited
A$4.35-0.68%
AFP.AXAFT Pharmaceuticals Limited
A$3.76+0.00%
PSQ.AXPacific Smiles Group Limited
A$2.18+0.00%
AVH.AXAVITA Medical, Inc.
A$2.80+1.08%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$224.41+0.03%
PCGPG&E
$13.33-0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.37+0.00%
NUNu Holdings
$15.40+0.07%

Questions About IMR

What is the current price of Imricor Medical Systems?

Imricor Medical Systems is trading at A$1.84 per share.

What is the 52-week range for Imricor Medical Systems?

Over the past 52 weeks, Imricor Medical Systems has traded between A$1.28 and A$2.25.

How much debt does Imricor Medical Systems have?

As of the most recent reporting period, Imricor Medical Systems reported total debt of $49.11M.

How much cash does Imricor Medical Systems have on hand?

Imricor Medical Systems reported $67.06M in cash and cash equivalents in its most recent financial results.

What is Imricor Medical Systems’s dividend yield?

Imricor Medical Systems does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services